Interpret
Reading File
Finding Sources
Searching PubMed
"non-alcoholic fatty liver disease" AND "grade" AND "ultrasound"
Reading File
Finding Sources
Finding Sources
Searching the Web
Grade II fatty liver ultrasound meaning management NAFLD
Here is a detailed interpretation of this ultrasound report for Mr. Prateek Mahajan, 37-year-old male:
Ultrasound Abdomen & Pelvis — Report Interpretation
Organ-by-Organ Findings
| Organ | Finding | Significance |
|---|---|---|
| Liver | 15.2 cm, increased echogenicity, no focal lesions; portal vein (PV) & common bile duct (CBD) normal; no biliary dilatation | Abnormal — Grade II fatty infiltration |
| Gallbladder | Distended, no stones/wall thickening/pericholecystic fluid | Normal |
| Pancreas | Head & body normal; tail obscured by bowel gas | Partially visualized — no concerning finding seen |
| Spleen | 9.1 cm, normal echo, no focal lesions | Normal |
| Right Kidney | 10.1 cm, normal, no calculi/hydronephrosis | Normal |
| Left Kidney | 9.8 cm, normal, no calculi/hydronephrosis | Normal |
| Urinary Bladder | Distended, no wall thickening, no calculi | Normal |
| Prostate | Normal size and echotexture | Normal |
| Free fluid | None | Normal |
Key Finding: Grade II Fatty Liver (Moderate Hepatic Steatosis)
This is the only abnormal finding. Fatty liver is graded on ultrasound based on echogenicity (brightness of liver compared to kidney):
| Grade | Sonographic Features | Fat Content (approx.) |
|---|---|---|
| Grade I (Mild) | Slightly increased liver echogenicity; diaphragm and vessels still visible | ~5–33% |
| Grade II (Moderate) | Moderately increased echogenicity; slightly obscured portal vein walls and diaphragm | ~33–66% |
| Grade III (Severe) | Markedly increased echogenicity; diaphragm and posterior liver poorly visualized | >66% |
At Grade II, fat makes up roughly one-third to two-thirds of the liver. The hallmark on ultrasound is diffuse increased echogenicity (the liver appears brighter than the kidney), with beginning obscuration of vessel margins. This is consistent with what the radiologist describes as "normal in size and increased echo-texture."
The liver measures 15.2 cm — this is within or at the upper limit of normal (normal sagittal span ~14–17 cm at the midclavicular line), so hepatomegaly is not present here (Yamada's Textbook of Gastroenterology).
What Causes Grade II Fatty Liver?
The most common causes in a 37-year-old male, in order of likelihood:
- Non-alcoholic fatty liver disease (NAFLD) — strongly associated with insulin resistance, obesity, metabolic syndrome, dyslipidemia, and type 2 diabetes
- Alcoholic fatty liver disease — requires clinical history
- Other: medications (steroids, amiodarone), hypothyroidism, hepatitis C
Clinical Implications
- Grade II is a warning stage — actionable but reversible with lifestyle changes
- The absence of focal lesions, normal portal vein, and no biliary dilatation is reassuring — no signs of cirrhosis or portal hypertension at this time
- Recommended next steps:
- Blood tests: Liver function tests (ALT, AST, GGT, ALP, bilirubin), fasting lipid profile, fasting glucose/HbA1c, TSH, Hepatitis B & C serology
- Fibroscan (transient elastography) or FIB-4 score to assess for underlying fibrosis/inflammation (NASH) — ultrasound alone cannot differentiate simple steatosis from steatohepatitis
- BMI and waist circumference assessment
- Lifestyle modification: Weight loss of 5–10% body weight significantly reduces hepatic fat; Mediterranean diet, alcohol avoidance, aerobic exercise (150–300 min/week)
- Follow-up ultrasound in 6–12 months to assess response
- No specific drug treatment is indicated at this stage unless metabolic co-morbidities (diabetes, dyslipidemia) are present
Summary
The scan is otherwise entirely normal. The only concern is moderate (Grade II) fatty liver, which is common in adults his age and is typically driven by metabolic factors. It is not an emergency, but warrants a metabolic workup and dedicated lifestyle intervention to prevent progression to non-alcoholic steatohepatitis (NASH), fibrosis, or cirrhosis.
How to stop metformin in a 60 year old male taking it from previous 5 years now presents with normal hba1c and fasting blood sugar on 90
Finding Sources
Searching PubMed
"metformin" AND "discontinuation" AND "type 2 diabetes" AND "glycemic control"
Searching the Web
when to stop metformin type 2 diabetes normal HbA1c guidelines deprescribing
Finding Sources
Reading Web Page
how to stop metformin deprescribing stepwise protocol HbA1c
Here is a structured clinical approach to stopping metformin in this patient:
Deprescribing Metformin in a 60-Year-Old with Normalised Glycaemia
First: Confirm the Context
Before stopping, establish why his sugars are normal:
| Question | Relevance |
|---|---|
| Has he lost significant weight / changed diet? | T2DM remission is achievable with weight loss ≥10–15% |
| Is his HbA1c truly in the normal range (≤5.6% / ≤38 mmol/mol) or just "well-controlled"? | Different implications |
| Fasting glucose 90 mg/dL (5 mmol/L) — normal and not over-treated | Reassuring |
| Any renal impairment (eGFR)? | May be an independent reason to stop |
| Is metformin the only drug, or are there others? | Deprescribing order matters |
| Any hypoglycaemic episodes? | Unlikely with metformin alone (low hypo risk) but relevant if on combination |
A fasting glucose of 90 mg/dL and normal HbA1c on metformin monotherapy is a valid indication for deprescribing, especially if driven by lifestyle improvement.
The Deprescribing Protocol
Metformin has a low hypoglycaemia risk, so the approach is a gradual stepwise dose reduction rather than abrupt cessation.
Typical metformin dose progression to stop:
| Step | Action | Duration |
|---|---|---|
| Step 1 | Reduce by 500–1000 mg (e.g., from 1000 mg BD → 500 mg BD or 1000 mg OD) | 3 months |
| Step 2 | Check HbA1c. If still at target → reduce further (e.g., 500 mg OD) | 3 months |
| Step 3 | Check HbA1c. If still normal → stop completely | — |
| Follow-up | Recheck HbA1c 3 months after stopping | Ongoing |
Each dose reduction step should be separated by ~3 months to allow HbA1c to reflect the change (HbA1c lags by 8–12 weeks).
Monitoring After Stopping
- Symptoms of hyperglycaemia: excessive thirst, polyuria, fatigue — counsel patient to watch for these
- HbA1c at 3 months post-cessation — this is the key safety check
- Fasting glucose periodically if patient has a glucometer
- If HbA1c rises above target after stopping → restart at lowest effective dose or consider lifestyle intensification
Key Considerations at Age 60
| Factor | Implication |
|---|---|
| Age 60 — not yet "elderly frail" | Standard deprescribing approach appropriate |
| 5 years on metformin | His beta-cell reserve may be partially preserved if lifestyle is good |
| Metformin's pleiotropic benefits | It has cardiovascular-neutral to mildly beneficial effects; also reduces risk of some cancers (colon, breast) — worth discussing |
| Renal function (eGFR) | Must be checked; if eGFR <30 ml/min, stopping is mandatory anyway |
| B12 levels | Long-term metformin (>3–5 years) causes B12 malabsorption in ~30% — check B12 and supplement if low |
When NOT to Stop Yet
- HbA1c is merely "well-controlled" (e.g., 6.5–7%) on metformin — the drug is doing its job
- No evidence of sustained lifestyle change that would maintain euglycaemia off the drug
- Patient on combination therapy — sulphonylureas and insulin should be deprescribed before metformin, as they carry higher hypo risk
Bottom Line
In this 60-year-old with a normal HbA1c and fasting glucose of 90 mg/dL on metformin monotherapy, deprescribing is appropriate. The recommended approach is:
- Reduce dose by 500–1000 mg every 3 months
- Check HbA1c at each step
- Stop completely once the lowest dose still keeps levels normal, then recheck at 3 months
- Check B12 — after 5 years on metformin this is due regardless
- Counsel on lifestyle maintenance — this is what will sustain remission after stopping
55year old female presents with leg swelling which resolves on taking rest and has no pain
Reading File
Finding Sources
Finding Sources
Searching the Web
55 year old female bilateral leg swelling painless resolves with rest differential diagnosis causes
Finding Sources
Finding Sources
Reading File
Reading File
This is a clinically rich presentation. Here is a systematic interpretation:
55-Year-Old Female — Painless Leg Swelling Relieved by Rest
Characterising the Oedema — What the History Already Tells Us
| Feature | Clinical Significance |
|---|---|
| Painless | Rules out DVT, cellulitis, acute arterial ischaemia, compartment syndrome |
| Resolves with rest / limb elevation | Strongly suggests venous or systemic (hydrostatic) oedema — NOT lymphoedema (lymphoedema does NOT respond to elevation) |
| 55-year-old female | Post-menopausal age → venous insufficiency, cardiac, thyroid, or hormonal causes more common |
| Bilateral assumed | Points to systemic causes; unilateral would push toward local venous/lymphatic pathology |
Differential Diagnosis (Most to Least Likely)
🔴 Top Priority — Must Rule Out First
1. Chronic Venous Insufficiency (CVI)
Most likely diagnosis in a 55-year-old female. Caused by incompetent venous valves → ambulatory venous hypertension → oedema. Key features:
- Worse after prolonged standing/sitting, improves with leg elevation
- Pitting oedema, typically at ankles, extending upward
- May have varicose veins, skin hyperpigmentation, eczema around medial malleolus
- No pain unless complicated by ulcers or superficial thrombophlebitis
2. Orthostatic / Dependent Oedema
Fluid accumulation due to gravity from prolonged standing or sitting (common in perimenopausal women). Fully resolves with rest. No underlying pathology.
🟡 Systemic Causes — Screen For These
| Cause | Clue |
|---|---|
| Heart failure (right-sided or biventricular) | Bilateral pitting oedema, JVP raised, breathlessness, orthopnoea |
| Hypothyroidism | Non-pitting/myxoedema, fatigue, cold intolerance, dry skin, constipation — common in women this age |
| Hypoalbuminaemia (nephrotic syndrome, cirrhosis, malnutrition) | Bilateral soft pitting oedema, frothy urine (nephrotic), jaundice (liver) |
| Renal failure / CKD | Periorbital oedema too, hypertension |
| Anaemia | High-output state can cause oedema |
🟢 Other Causes to Consider
| Cause | Notes |
|---|---|
| Medications | Amlodipine (CCBs), NSAIDs, steroids, hormones (HRT/OCPs), gabapentin, pioglitazone — ask full drug history |
| Lymphoedema (early/Stage I) | Soft pitting at this stage, may mimic venous oedema; but typically does NOT resolve with overnight elevation |
| Lipedema | Bilateral symmetric fatty enlargement of legs, spares feet; NOT pitting, NOT relieved by elevation; common in women; often misdiagnosed as oedema |
| Pelvic mass / compression | Bilateral venous outflow obstruction — gynaecological cause important at this age |
| Pregnancy-related / post-menopausal hormonal | Less relevant unless on HRT |
Approach — History and Examination
Key questions to ask:
- Bilateral or unilateral? Which part of leg?
- Time of day — worse in evening? (venous) or constant? (lymphatic/systemic)
- Any breathlessness, orthopnoea, PND? (cardiac)
- Weight gain? Fatigue? Cold intolerance? (hypothyroid)
- Frothy urine? (nephrotic)
- Any medications, especially CCBs or HRT?
- History of varicose veins, DVT, pelvic surgery?
- BMI — obesity strongly associated with CVI and dependent oedema
Examination:
- Pitting vs non-pitting (press for 5 seconds over medial malleolus)
- Stemmer sign (inability to pinch skin at base of 2nd toe — positive in lymphoedema)
- JVP, S3 gallop, crackles (cardiac)
- Skin: hyperpigmentation, lipodermatosclerosis, varicosities (CVI)
- Abdomen: ascites, hepatomegaly (liver disease)
- Thyroid examination
Investigations
| Test | Purpose |
|---|---|
| Serum albumin, LFTs | Liver disease, hypoalbuminaemia |
| Urine dipstick + spot urine protein:creatinine | Nephrotic syndrome |
| TSH | Hypothyroidism — high yield in 55F |
| BNP / NT-proBNP | Heart failure screen |
| FBC | Anaemia |
| Renal function (creatinine, eGFR) | CKD |
| Venous duplex ultrasound (lower limbs) | Gold standard for CVI; rules out DVT |
| ECG + Echo | If cardiac cause suspected |
| Pelvic ultrasound | If pelvic mass suspected |
Most Likely Diagnosis in This Case
Given:
- Painless oedema
- Relieves completely with rest (elevation-responsive)
- 55-year-old female (post-menopausal)
- No mention of breathlessness, jaundice, or systemic symptoms
→ Chronic Venous Insufficiency or simple dependent/orthostatic oedema is the most probable cause, with hypothyroidism and calcium channel blocker use being important and easily treatable differentials to exclude first with basic bloods.
— Harrison's Principles of Internal Medicine 22E; Sabiston Textbook of Surgery, 11th Ed
Create a quick reference guide for oedema workup
Asking for Preferences
Reading File
Finding Sources
Finding Sources
Running Command
Writing File
Running Command
Running Command
Your quick reference guide is ready:
Oedema Workup Quick Reference
PDF Document · PDF
What's included in the guide:
| Section | Content |
|---|---|
| Step 1 — Classify | Pitting vs non-pitting table; Unilateral vs bilateral differential diagnosis |
| Step 2 — History | 12-question key history table with diagnostic pointers; Red flags box (DVT, acute HF, cellulitis, PE) |
| Step 3 — Examination | 12-sign examination table with diagnoses (Stemmer sign, JVP, S3, varicosities, etc.) |
| Step 4 — Investigations | Tiered approach: Tier 1 (all patients) + Tier 2 (directed by suspicion) |
| Step 5 — Management | 9 diagnoses with first-line treatment and referral criteria |
| Wells DVT Score | Full scoring table + colour-coded interpretation (Low/Moderate/High) |
| Special Populations | Women >50y, elderly, pregnancy, cancer, CKD |
Formatted in a clean, colour-coded A4 layout suitable for printing or tablet use at the clinic.
This is a shared conversation. Sign in to Orris to start your own chat.